ImageBiopsy Lab

Austria
Vienna, Vienna, Austria, 1130

Company profile

ImageBiopsy Lab company profile

ImageBiopsy Lab (IBL) is the global leader in developing and certifying state-of-the-art AI-based software for image analyses and workflow tasks in musculoskeletal (MSK) radiology, orthopaedic surgery and traumatology. Our deep tech platform has been built to automatically read and prioritize the large numbers of low-risk, low reimbursement plainfilm MSK X-rays, thus freeing valuable physician resources and significantly reducing manual reporting steps. Our ultimate mission is to cover all clinically relevant MSK/orthopaedic use cases – from low-risk plain film X-ray to complex MRI/CT. For that purpose we have established strong ties with leading US/EU medical institutions in order to provide us with an ever-growing number of training data, expert-annotators & validation resources, thus enabling us to expand our platform from plain film X-ray to MRI and CT. IBL has offices in Europe and the US and has a growing number of distinct AI-modules in FDA/CE and research-only certification stages, covering a large portion of the most common MSK-X-ray use cases.

Business identity

Contact email
[email protected]
Phone number
+439051206
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2016-11-30

Headquarters

Postal code
1130
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$4.3M
Last funding
Series A / 2023-07-31
Last equity funding
Series A
Investors
4
Lead investors
1
Founders
4
Articles
16

Founders and investors

Founders

Christoph GötzDavul LjuharPhilip MeierRichard Ljuhar

Lead investors

APEX Ventures

Investors

APEX Venturesaws GründungsfondsIT-FarmVienna Business Agency